Drawing for ALLERGY UNLOCKED

USPTO serial 79154606

ALLERGY UNLOCKED

Reviewed by CopyMark Law Group

Reg. 4774784Status 404
Filing date
Status date
Registration date
Jul 21, 2015
Examiner
JACKSON, STEVEN W
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALLERGY UNLOCKED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

B. Brett Heavner

B. Brett Heavner Finnegan, Henderson, Farabow, Garrett &901 New York Avenue, NWWashington, DC 20001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in research and science; diagnostic preparations for scientific or research purposesSECTION 71 - CANCELLED—
005Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma and respiratory allergic diseases; diagnostic preparations for medical purposes, namely, diagnostic preparations for the treatment, monitoring and diagnosing of diseases such as allergies, asthma, rhinitis and respiratory diseases, diagnostic reagents for medical use; pharmaceutical preparations in the form of injectable pharmaceuticals, particularly adrenaline, for treatment of anaphylactic reactions; prefilled injectors containing pharmaceutical preparations, substances and medicines, particularly adrenalineSECTION 71 - CANCELLED—
010Medical diagnostic test kits sold empty for diagnosing allergies; inhalers for medical purposes; medical syringes and medical fluid injectors for treatment of anaphylactic reactions; medical fluid injectors intended for pharmaceutical preparations, substances and medicines, particularly adrenaline for use in the treatment of allergies, asthma, allergic rhinitis, allergic asthma and respiratory allergic diseases; hypodermic injectors and holders for hypodermic injectors, namely, hypodermic needles and hypodermic syringes; structural parts and fittings for all the aforesaid goodsSECTION 71 - CANCELLED—
042Scientific, technological, medical and pharmacological research services and design relating thereto, namely, scientific research, medical research and pharmaceutical research services; scientific and medical laboratory services; conducting clinical trials for othersSECTION 71 - CANCELLED—
044Medical services and medical healthcare services; medical consulting services, namely, counselling and information regarding immunotherapy, allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions; providing patient support relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions, also electronically or digitally, namely, medical consultations; providing medical information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions, also electronically or digitally, through a website; medical diagnostic services, namely, performing diagnosis of diseasesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 1, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Nov 1, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 20, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Oct 26, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 26, 2022INPCINVALIDATION PROCESSED—
Oct 4, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 4, 2022C71TCANCELLED SECTION 71—
Jul 21, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 23, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 15, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 31, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 10, 2015XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Dec 10, 2015XXCRGENERIC MADRID TRANSACTION CREATED—
Oct 21, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 21, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 5, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 5, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 2, 2015GPNXNOTIFICATION PROCESSED BY IB—
Apr 15, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 15, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 15, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 31, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 31, 2015ATRVATTORNEY REVIEW COMPLETED—
Mar 17, 2015ALIEASSIGNED TO LIE—
Mar 17, 2015CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Mar 12, 2015CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Feb 26, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 25, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 25, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 25, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2014RFNTREFUSAL PROCESSED BY IB—
Nov 29, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 29, 2014RFRRREFUSAL PROCESSED BY MPU—
Nov 26, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 25, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 22, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 18, 2014DOCKASSIGNED TO EXAMINER—
Nov 18, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 17, 2014LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 13, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance